Plasma antioxidant activity and vascular dementia

被引:46
作者
Ryglewicz, D [1 ]
Rodo, M [1 ]
Kunicki, PK [1 ]
Bednarska-Makaruk, M [1 ]
Graban, A [1 ]
Lojkowska, W [1 ]
Wehr, H [1 ]
机构
[1] Natl Inst Cardiol, Inst Psychiat & Neurol, Warsaw, Poland
关键词
vascular dementia; alpha-tocopherol; oxidative stress; antioxidant defense; oxidative modification of LDL; lipids;
D O I
10.1016/S0022-510X(02)00290-3
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Little is known about the role of antioxidant activity in the pathogenesis of stroke-associated neuronal damage and impairment following a stroke. Increased free radical formation together with reduced antioxidant defense may increase neuronal injury. A low concentration of antioxidants such as alpha-tocopherol may influence the development of post-stroke dementia. The aim of this study was to evaluate the level of alpha-tocopherol and susceptibility of LDL to oxidation in a group of patients with dementia in comparison to controls. In a group of 68 patients with dementia, according to DSM-IV criteria, 42 with vascular dementia (VaD), 26 with Alzheimer type of dementia (AD) and 46 age-matched persons, with no signs of cognitive disorders (control group), we measured lipids, alpha-tocopherol and the kinetics of LDL oxidation. The levels of triglycerides (TG) and low-density lipoprotein (LDL) were significantly lower in patients with VaD in comparison to AD patients, but the atherogenic index was similar in both groups. alpha-Tocopherol was significantly lower in patients with VaD in comparison to patients with AD and controls: 9.9, 12.6 and 12.6 ng/ml, respectively, p < 0.0001. Susceptibility of LDL to oxidation, measured by duration of lag phase did not reveal statistically significant differences between the groups. In patients with VaD, low levels of plasma alpha-tocopherol were observed, which indicate a reduced antioxidant defense in these subjects. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:195 / 197
页数:3
相关论文
共 50 条
[41]   Drugs and vascular dementia [J].
Allain, H ;
Bentue-Ferrer, D ;
Tribut, O ;
Pinel, JF .
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2003, 16 (01) :1-6
[42]   Nutrition and vascular dementia [J].
L. Perez ;
L. Helm ;
A. Dean Sherzai ;
K. Jaceldo-Siegl ;
A. Sherzai .
The journal of nutrition, health & aging, 2012, 16 :319-324
[43]   Recognizing vascular dementia [J].
Gabriel Gold .
Annals of General Psychiatry, 7 (Suppl 1)
[44]   Effect of single bout of maximal excercise on plasma antioxidant status and paraoxonase activity in young sportsmen [J].
Otocka-Kmiecik, A. ;
Lewandowski, M. ;
Stolarek, R. ;
Szkudlarek, U. ;
Nowak, D. ;
Orlowska-Majdak, M. .
REDOX REPORT, 2010, 15 (06) :275-281
[45]   Treatment of vascular dementia [J].
Okamoto, K ;
Tanaka, M ;
Kondo, S .
ALZHEIMER'S DISEASE: VASCULAR ETIOLOGY AND PATHOLOGY, 2002, 977 :507-512
[46]   Pathophysiology of vascular dementia [J].
Iemolo F. ;
Duro G. ;
Rizzo C. ;
Castiglia L. ;
Hachinski V. ;
Caruso C. .
Immunity & Ageing, 6 (1)
[47]   Genetics in vascular dementia [J].
Manso-Calderon, Raquel .
FUTURE NEUROLOGY, 2019, 14 (01)
[48]   Subcortical vascular dementia [J].
Erkinjuntti, T .
CEREBROVASCULAR DISEASES, 2002, 13 :58-60
[49]   Rivastigmine in vascular dementia [J].
Vincent, S ;
Lane, R .
INTERNATIONAL PSYCHOGERIATRICS, 2003, 15 :201-205
[50]   Rivastigmine in vascular dementia [J].
Moretti, R ;
Torre, P ;
Antonello, RM ;
Cazzato, G ;
Bava, A .
EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (06) :1399-1410